AstraZeneca Faces Sanctions In Seroquel MDL
The Florida court overseeing multidistrict products liability litigation over AstraZeneca LP's anti-psychotic drug Seroquel has ruled that the pharmaceutical company engaged in sanctionable conduct, granting in part a motion that accused...To view the full article, register now.
Already a subscriber? Click here to view full article